Tag: chronic kidney failure

Family Doctors Omit Tests for Kidney Disease in Type 2 Diabetes

Nikita Stempniewicz U.S. primary care physicians are not properly checking patients with type 2 diabetes for chronic kidney disease (CKD) nearly as often as they...

Kidney Transplant Outcomes Good in Undocumented Immigrants

Undocumented immigrants with end-stage renal disease who underwent kidney transplantation had outcomes that were as good as, if not better than, those in the general...

Dapagliflozin Safe, Protective in Advanced Kidney Disease

Patients with stage 4 chronic kidney disease (CKD) who were in the DAPA-CKD trial had cardiorenal benefits from dapagliflozin that were similar to those of...

FDA Approves Finerenone for Slowing CKD in Type 2 Diabetes

The US Food and Drug Administration (FDA) approved finerenone (Kerendia), the first agent from a new class of nonsteroidal mineralocorticoid receptor antagonists (MRAs), on July...

Prominent Nephrologist, Mount Sinai Chair of Medicine Dies

Dr Barbara T. Murphy Barbara T. Murphy, MD, renowned nephrologist and professor of medicine at Mount Sinai School of Medicine in New York City, has...

Worse Survival With Recurrent AIH After Transplant

Autoimmune hepatitis that recurs following a liver transplant can impair both graft survival and overall survival, results of a large international study showed. Among 736...

Hypomethylating Agents in Children With Relapsed/Refractory AML

Hypomethylating agents are generally considered to be agents of choice for older adults with acute myeloid leukemia who cannot tolerate the rigors of more intensive...

New Transplant Policy Doesn’t Benefit All States

The introduction of the new kidney allocation policy in the US initiated by the Organ Procurement and Transplantation Network (OPTN) may not benefit all states...

Finerenone Cuts New AF in Type 2 Diabetes and CKD

Finerenone treatment of patients with type 2 diabetes and diabetic kidney disease was linked to a significant drop in the incidence of new-onset atrial fibrillation as...

Pharmacist + App Cuts Errors, Hospitalization After Transplant

A pharmacist-led intervention that involves use of a smartphone app with home monitoring significantly reduced medication errors, adverse events, and hospitalizations among kidney transplant patients,...

FDA Approves Dapagliflozin (Farxiga) for Chronic Kidney Disease

The US Food and Drug Administration (FDA) has approved dapagliflozin (Farxiga, AstraZeneca) to reduce the risk for kidney function decline, kidney failure, cardiovascular death, and...

Vadadustat for Anemia in Chronic Kidney Disease: Questions Remain

Oral vadadustat, one of a new class of hypoxia-inducible factor prolyl hydroxylase inhibitors (HIF-PHIs), is effective in the treatment of anemia in people with chronic...

Many Postsurgical Hospital Readmissions Preventable

Nearly 1 in 5 postsurgical hospital readmissions are potentially preventable, and failure to prevent them costs the healthcare system almost $300 million annually, according to...

Study Enhances Understanding of Prurigo Nodularis

Patients with prurigo nodularis tend to make a greater number of visits to health care specialists and are burdened by a greater number of medical...

Task Force Reviewing Race Modifier in eGFR Issues Interim Report

The race coefficient now used in calculating estimated glomerular filtration rate (eGFR) in US patients who self-identify as Black will soon change, says a task...

Difelikefalin Safe, Effective for Kidney Disease-Associated Pruritus

Difelikefalin, an investigational intravenous (IV) drug for treating itch (pruritus) in patients with end-stage renal disease on hemodialysis, was safe and effective in two parallel...

Troubling Trends for Infective Endocarditis in Dialysis Patients

The occurrence of endocarditis in hemodialysis patients may be significantly higher than previously thought, but it is as lethal as ever, a new observational study...

Vasodilatory Medications Found Protective Against Rosacea

Vasodilators may have a protective effect against rosacea, results from a single-center retrospective cohort study showed. “Our initial hypothesis was that perhaps antihypertensive agents might...

‘Major Update’ of BP Guidance for Kidney Disease

The new 2021 Kidney Disease: Improving Global Outcomes (KDIGO) clinical practice guideline for blood pressure management for adults with chronic kidney disease (CKD) who are...

Blood Test Predicts Organ Rejection Risk After Kidney Transplant

A functional immunologic assay that could easily be incorporated into routine laboratory work can predict which patients are at high risk for rejection of their...

Springboard Needed to Boost Access to Living Donor Kidney Transplants

A new study indicates numerous ways in which transplant teams can try to reduce disparities that currently mean that Black patients are far less likely...

Cardiometabolic Subspecialty Is ‘One-Stop Shop’ Approach to Diabetes

A one-stop shop approach to managing the spectrum of complications in patients with type 2 diabetes with a coordinated, multidisciplinary team of clinicians has taken...

Race Modifier Means Black Patients Miss Out on Kidney Transplants

New evidence further confirms that use of the race coefficient when calculating estimated glomerular filtration rate (eGFR) in Black patients with chronic kidney disease (CKD)...

Medicare Coverage of Kidney Transplant Drugs Is Extended

A newly passed US law ensures, starting in 2023, that for Medicare patients who receive a kidney transplant, insurance coverage of immunosuppressant drugs that prevent...

Acute Kidney Injury With COVID-19 Seems to Be Declining in US

Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. Among US veterans hospitalized with COVID-19, about one third experienced acute...